Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2025-12-27 @ 3:19 AM
Study NCT ID:
NCT05811793
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-04-13
First Post:
2023-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
Sponsor:
Second Affiliated Hospital of Nanchang University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-21
First Submit QC Date:
None
Study First Post Date:
2023-04-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-12
Last Update Post Date:
2023-04-13
Last Update Post Date Type:
ACTUAL